Page 58 - 74_04

M. FRESNO Y COLS. AN. R. ACAD. NAC. FARM

(2002) Cyclooxygenase-2 promotes early atherosclerotic lesion formation in
LDL receptor-deficient mice. Circulation. 105: 1816-1823.
(76) FOSSLIEN, E. (2005) Cardiovascular complications of non-steroidal anti-
inflammatory drugs. Ann. Clin. Lab. Sci. 35: 347-385.
(77) RAY, W. A.; STEIN, C. M.; DAUGHERTY, J. R.; HALL, K.; ARBOGAST, P. G. AND
GRIFFIN, M. R. (2002) COX-2 selective non-steroidal anti-inflammatory drugs
and risk of serious coronary heart disease. Lancet. 360: 1071-1073.
(78) MARTINEZ-GONZALEZ, J. AND BADIMON, L. (2007) Mechanisms underlying the
cardiovascular effects of COX-inhibition: benefits and risks. Curr. Pharm.
Des. 13: 2215-2227.
(79) BABAEV, V. R.; DING, L.; REESE, J.; MORROW, J. D.; BREYER, M. D.; DEY, S.
K.; FAZIO, S. AND LINTON, M. F. (2006) Cyclooxygenase-1 deficiency in bone
marrow cells increases early atherosclerosis in apolipoprotein E- and low-
density lipoprotein receptor-null mice. Circulation. 113: 108-117.
(80) BURLEIGH, M. E.; BABAEV, V. R.; YANCEY, P. G.; MAJOR, A. S.; MCCALEB, J.
L.; OATES, J. A.; MORROW, J. D.; FAZIO, S. AND LINTON, M. F. (2005)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-
deficient and C57BL/6 mice. J. Mol. Cell. Cardiol. 39: 443-452.
(81) PRATICO, D.; TILLMANN, C.; ZHANG, Z. B.; LI, H. AND FITZGERALD, G. A.
(2001) Acceleration of atherogenesis by COX-1-dependent prostanoid
formation in low density lipoprotein receptor knockout mice. Proc. Natl.
Acad. Sci. U S A. 98: 3358-3363.
(82) REISS, A. B. AND EDELMAN, S. D. (2006) Recent insights into the role of
prostanoids in atherosclerotic vascular disease. Curr. Vasc. Pharmacol. 4:
395-408.
(83) YAMADA, M.; NUMAGUCHI, Y.; OKUMURA, K.; HARADA, M.; NARUSE, K.;
MATSUI, H.; ITO, T. AND HAYAKAWA, T. (2002) Prostacyclin synthase gene
transfer modulates cyclooxygenase-2-derived prostanoid synthesis and
inhibits neointimal formation in rat balloon-injured arteries. Arterioscler.
Thromb. Vasc. Biol. 22: 256-262.
(84) EGAN, K. M.; LAWSON, J. A.; FRIES, S.; KOLLER, B.; RADER, D. J.; SMYTH, E.
M. AND FITZGERALD, G. A. (2004) COX-2-derived prostacyclin confers
atheroprotection on female mice. Science. 306: 1954-1957.
(85) LOPEZ, J. A.; ARMSTRONG, M. L.; HARRISON, D. G.; PIEGORS, D. J. AND
HEISTAD, D. D. (1989) Vascular responses to leukocyte products in
atherosclerotic primates. Circ. Res. 65: 1078-1086.
(86) WANG, M.; ZUKAS, A. M.; HUI, Y.; RICCIOTTI, E., PURE, E. AND FITZGERALD,
G. A. (2006) Deletion of microsomal prostaglandin E synthase-1 augments
prostacyclin and retards atherogenesis. Proc. Natl. Acad. Sci. U S A. 103:
14507-14512.
(87) CIPOLLONE, F.; FAZIA, M.; IEZZI, A.; CIABATTONI, G.; PINI, B.; CUCCURULLO,
C.; UCCHINO, S.; SPIGONARDO, F.; DE LUCA, M.; PRONTERA, C.; CHIARELLI,
F.; CUCCURULLO, F. AND MEZZETTI, A. (2004) Balance between PGD

22